The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

J D Eaton, I A Clarke, H Pandha, A G Dalgleish, R S Kirby

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)S10
    JournalProstate Cancer and Prostatic Diseases
    Volume3
    Issue numberS1
    DOIs
    Publication statusPublished - 2000

    Cite this

    The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer. / Eaton, J D; Clarke, I A; Pandha, H; Dalgleish, A G; Kirby, R S.

    In: Prostate Cancer and Prostatic Diseases, Vol. 3, No. S1, 2000, p. S10.

    Research output: Contribution to journalArticle

    Eaton, J D ; Clarke, I A ; Pandha, H ; Dalgleish, A G ; Kirby, R S. / The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer. In: Prostate Cancer and Prostatic Diseases. 2000 ; Vol. 3, No. S1. pp. S10.
    @article{018fcd8f66db4bc49e1cc4443e67e904,
    title = "The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer",
    author = "Eaton, {J D} and Clarke, {I A} and H Pandha and Dalgleish, {A G} and Kirby, {R S}",
    year = "2000",
    doi = "10.1038/sj.pcan.4500449",
    language = "English",
    volume = "3",
    pages = "S10",
    journal = "Prostate Cancer and Prostatic Diseases",
    issn = "1365-7852",
    publisher = "Nature Publishing Group",
    number = "S1",

    }

    TY - JOUR

    T1 - The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

    AU - Eaton, J D

    AU - Clarke, I A

    AU - Pandha, H

    AU - Dalgleish, A G

    AU - Kirby, R S

    PY - 2000

    Y1 - 2000

    U2 - 10.1038/sj.pcan.4500449

    DO - 10.1038/sj.pcan.4500449

    M3 - Article

    VL - 3

    SP - S10

    JO - Prostate Cancer and Prostatic Diseases

    JF - Prostate Cancer and Prostatic Diseases

    SN - 1365-7852

    IS - S1

    ER -